QXO Inc (NYSE:QXO) has a beta value of 2.25 and has seen 0.43 million shares traded in the recent trading session. The company, currently valued at $5.79B, closed the recent trade at $14.13 per share which meant it lost -$0.05 on the day or -0.32% during that session. The QXO stock price is -1952.37% off its 52-week high price of $290.00 and 24.91% above the 52-week low of $10.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.74 million shares traded. The 3-month trading volume is 2.47 million shares.
QXO Inc (NYSE:QXO) trade information
Sporting -0.32% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QXO stock price touched $14.13 or saw a rise of 3.15%. Year-to-date, QXO Inc shares have moved -11.10%, while the 5-day performance has seen it change 4.24%. Over the past 30 days, the shares of QXO Inc (NYSE:QXO) have changed 10.34%. Short interest in the company has seen 9.35 million shares shorted with days to cover at 4.41.
QXO Inc (QXO) estimates and forecasts
The company’s shares have lost -10.37% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 4,392.47%. 1 analysts offering their estimates for the company have set an average revenue estimate of 12M for the current quarter. 1 have an estimated revenue figure of 13M for the next ending quarter. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 55.18% over the past 5 years.
QXO Dividends
QXO Inc is expected to release its next earnings report on 2025-Mar-03 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
QXO Inc (NYSE:QXO)’s Major holders
Insiders own 0.11% of the company shares, while shares held by institutions stand at 84.45% with a share float percentage of 84.55%. Investors are also buoyed by the number of investors in a company, with QXO Inc having a total of 218.0 institutions that hold shares in the company. The top two institutional holders are CITADEL ADVISORS LLC with over 9.3 million shares worth more than $85.09 million. As of 2024-06-30, CITADEL ADVISORS LLC held 2.5922% of shares outstanding.
The other major institutional holder is DRIEHAUS CAPITAL MANAGEMENT LLC, with the holding of over 2.24 million shares as of 2024-06-30. The firm’s total holdings are worth over $20.49 million and represent 0.6247% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Advisor Managed Portfolios-Patient Opportunity Trust and T. Rowe Price Small-Cap Stock Fund, Inc. As of Dec 31, 2024, the former fund manager holds about 1.47% shares in the company for having 6.0 shares of worth $84.96 million while later fund manager owns 4.82 shares of worth $68.28 million as of Dec 31, 2024, which makes it owner of about 1.18% of company’s outstanding stock.
